Imagine owning or operating a business in which your best customers pretty much dictate your prices. In that same business, you face an organized effort to tell you when and how you can practice your trade, and those guidelines are often contrary to what you have been trained to do. Imagine, too, that your business also experiences skyrocketing

In a world of PACS and enterprise imaging, the performance of the enterprise viewer often takes a back seat. For Brad Levin, an imaging veteran of more than two decades, it’s a mystifying mindset since the diagnostic workstation (viewer) is literally the front seat of a radiologist’s day-to-day existence.

Call it a classic case of not wanting to be the last kid on the block to own one.

How much would an extra $44,000 government stipend mean to your radiology practice? Would it be enough to cover the hassle of diving into the attestation to meaningful use of health IT? To date, many practices have declined to participate, according to David Avrin, MD, PhD, of the University of California–San Francisco. On September 9, in San

While the news crews have moved on to coverage of the final rule for stage 2 meaningful use, the reality is this: The vast majority of radiology practices still has not met the stage 1 requirements. Their greatest challenge is likely to be understanding how the rule applies to their practice setting, and radiology practices are interpreting that in

On August 23, CMS released the final rule for stage 2 meaningful use of health IT. Unlike the stage 1 rule, the stage 2 rule contains myriad radiology-specific portions that might have radiologists in a state of confusion, but things could be simpler than they seem. RadInformatics.com recently conferred with Alberto Goldszal, PhD, MBA, CIO of

The image of the lone physician “listening for zebras” as he combs through a mental library of diagnoses is fast becoming a thing of the past. Some answers are objectively better than others, so the only real question is how to conveniently get those answers.

The vendor-research company KLAS is perhaps best known for its market reports, which compare the performance of multiple vendors in a single product category. Recently, however, the company has introduced a new approach to its reports that is reflective of the growing need to evaluate emerging technologies prior to widespread adoption and